HEADER TOXIN 06-DEC-21 7QFP TITLE CRYO-EM STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE E COMPND MOL_ID: 1; COMPND 2 MOLECULE: BOTULINUM NEUROTOXIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CLOSTRIDIUM BOTULINUM; SOURCE 3 ORGANISM_TAXID: 1491; SOURCE 4 GENE: BONT; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS CLOSTRIDIUM BOTULINUM, NEUROTOXIN, TOXIN EXPDTA ELECTRON MICROSCOPY AUTHOR S.KOSENINA,M.MARTINEZ-CARRANZA,J.R.DAVIES,G.MASUYER,P.STENMARK REVDAT 2 02-FEB-22 7QFP 1 JRNL REVDAT 1 26-JAN-22 7QFP 0 JRNL AUTH S.KOSENINA,M.MARTINEZ-CARRANZA,J.R.DAVIES,G.MASUYER, JRNL AUTH 2 P.STENMARK JRNL TITL STRUCTURAL ANALYSIS OF BOTULINUM NEUROTOXINS TYPE B AND E BY JRNL TITL 2 CRYO-EM. JRNL REF TOXINS V. 14 2021 JRNL REFN ESSN 2072-6651 JRNL PMID 35050991 JRNL DOI 10.3390/TOXINS14010014 REMARK 2 REMARK 2 RESOLUTION. 3.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : EPU, CRYOSPARC, PHENIX, COOT, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.700 REMARK 3 NUMBER OF PARTICLES : 284390 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7QFP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1292119527. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : BOTULINUM NEUROTOXIN SEROTYPE E REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 0.10 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 18282 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : TFS KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON III (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5500.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 HIS A 3 REMARK 465 HIS A 4 REMARK 465 HIS A 5 REMARK 465 HIS A 6 REMARK 465 HIS A 7 REMARK 465 HIS A 8 REMARK 465 HIS A 9 REMARK 465 HIS A 10 REMARK 465 HIS A 11 REMARK 465 GLU A 12 REMARK 465 ASP A 13 REMARK 465 LEU A 14 REMARK 465 TYR A 15 REMARK 465 PHE A 16 REMARK 465 GLN A 17 REMARK 465 SER A 18 REMARK 465 PRO A 19 REMARK 465 PRO A 516 REMARK 465 LYS A 517 REMARK 465 TYR A 518 REMARK 465 ASP A 519 REMARK 465 SER A 520 REMARK 465 ASN A 521 REMARK 465 GLY A 522 REMARK 465 THR A 523 REMARK 465 SER A 524 REMARK 465 ASP A 525 REMARK 465 ILE A 526 REMARK 465 GLU A 527 REMARK 465 GLN A 528 REMARK 465 HIS A 529 REMARK 465 ASP A 530 REMARK 465 VAL A 531 REMARK 465 ASN A 532 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 498 C - N - CA ANGL. DEV. = 9.5 DEGREES REMARK 500 PRO A 941 C - N - CA ANGL. DEV. = 9.6 DEGREES REMARK 500 CYS A 959 CA - CB - SG ANGL. DEV. = 6.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 26 -175.60 68.92 REMARK 500 ASN A 31 -1.08 -48.27 REMARK 500 ILE A 52 -67.99 -98.39 REMARK 500 PRO A 88 43.47 -84.64 REMARK 500 PHE A 153 -70.26 -65.28 REMARK 500 ASN A 155 32.22 -141.96 REMARK 500 HIS A 193 50.05 -91.51 REMARK 500 ASP A 213 -62.38 -93.70 REMARK 500 ASN A 214 48.40 -96.87 REMARK 500 LEU A 238 45.08 -91.41 REMARK 500 THR A 245 45.18 -93.14 REMARK 500 PRO A 315 43.92 -84.64 REMARK 500 THR A 352 -169.50 -100.36 REMARK 500 SER A 389 -60.65 -94.71 REMARK 500 CYS A 429 179.05 74.94 REMARK 500 ASN A 431 -122.12 58.95 REMARK 500 ASN A 448 -142.74 -103.63 REMARK 500 LEU A 451 -62.72 -127.59 REMARK 500 ASN A 466 -157.54 -159.34 REMARK 500 LYS A 469 -133.31 -118.52 REMARK 500 GLU A 470 -99.25 -147.88 REMARK 500 ASP A 472 -68.25 -171.80 REMARK 500 ASP A 473 55.61 89.83 REMARK 500 ASN A 478 57.21 -90.90 REMARK 500 GLU A 482 -142.53 -136.14 REMARK 500 LEU A 490 -112.88 -104.31 REMARK 500 ASP A 502 -131.48 60.46 REMARK 500 ASN A 511 -169.83 -127.37 REMARK 500 LEU A 554 -123.13 -96.23 REMARK 500 ALA A 561 -138.15 52.56 REMARK 500 GLU A 564 -13.12 -48.58 REMARK 500 LYS A 567 -103.12 -129.85 REMARK 500 SER A 617 -61.34 -94.05 REMARK 500 ILE A 623 -58.73 -123.06 REMARK 500 LEU A 650 51.57 -91.10 REMARK 500 SER A 673 -61.68 -91.79 REMARK 500 ASN A 753 53.73 -95.83 REMARK 500 ASP A 756 -119.98 -88.77 REMARK 500 ILE A 760 -79.92 47.77 REMARK 500 ASN A 797 -42.54 -134.64 REMARK 500 GLN A 825 47.36 -91.15 REMARK 500 LEU A 836 17.73 -69.80 REMARK 500 SER A 866 -128.95 62.94 REMARK 500 SER A 867 -62.93 -29.49 REMARK 500 LEU A 870 44.79 -157.09 REMARK 500 ASN A 876 -125.08 60.80 REMARK 500 ASP A 926 -159.43 -148.12 REMARK 500 LYS A 928 115.93 -35.54 REMARK 500 TYR A 929 -75.16 -114.30 REMARK 500 PHE A 932 55.66 -152.69 REMARK 500 REMARK 500 THIS ENTRY HAS 62 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-13946 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE B DBREF 7QFP A 19 1268 UNP A8Y875 A8Y875_CLOBO 2 1251 SEQADV 7QFP MET A 1 UNP A8Y875 INITIATING METHIONINE SEQADV 7QFP GLY A 2 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 3 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 4 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 5 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 6 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 7 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 8 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 9 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 10 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP HIS A 11 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP GLU A 12 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP ASP A 13 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP LEU A 14 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP TYR A 15 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP PHE A 16 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP GLN A 17 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP SER A 18 UNP A8Y875 EXPRESSION TAG SEQADV 7QFP GLN A 230 UNP A8Y875 GLU 213 ENGINEERED MUTATION SEQADV 7QFP TYR A 233 UNP A8Y875 HIS 216 ENGINEERED MUTATION SEQADV 7QFP LYS A 1269 UNP A8Y875 EXPRESSION TAG SEQRES 1 A 1269 MET GLY HIS HIS HIS HIS HIS HIS HIS HIS HIS GLU ASP SEQRES 2 A 1269 LEU TYR PHE GLN SER PRO LYS ILE ASN SER PHE ASN TYR SEQRES 3 A 1269 ASN ASP PRO VAL ASN ASP ARG THR ILE LEU TYR ILE LYS SEQRES 4 A 1269 PRO GLY GLY CYS GLN GLU PHE TYR LYS SER PHE ASN ILE SEQRES 5 A 1269 MET LYS ASN ILE TRP ILE ILE PRO GLU ARG ASN VAL ILE SEQRES 6 A 1269 GLY THR THR PRO GLN ASP PHE HIS PRO PRO THR SER LEU SEQRES 7 A 1269 LYS ASN GLY ASP SER SER TYR TYR ASP PRO ASN TYR LEU SEQRES 8 A 1269 GLN SER ASP GLU GLU LYS ASP ARG PHE LEU LYS ILE VAL SEQRES 9 A 1269 THR LYS ILE PHE ASN ARG ILE ASN ASN ASN LEU SER GLY SEQRES 10 A 1269 GLY ILE LEU LEU GLU GLU LEU SER LYS ALA ASN PRO TYR SEQRES 11 A 1269 LEU GLY ASN ASP ASN THR PRO ASP ASN GLN PHE HIS ILE SEQRES 12 A 1269 GLY ASP ALA SER ALA VAL GLU ILE LYS PHE SER ASN GLY SEQRES 13 A 1269 SER GLN ASP ILE LEU LEU PRO ASN VAL ILE ILE MET GLY SEQRES 14 A 1269 ALA GLU PRO ASP LEU PHE GLU THR ASN SER SER ASN ILE SEQRES 15 A 1269 SER LEU ARG ASN ASN TYR MET PRO SER ASN HIS GLY PHE SEQRES 16 A 1269 GLY SER ILE ALA ILE VAL THR PHE SER PRO GLU TYR SER SEQRES 17 A 1269 PHE ARG PHE ASN ASP ASN SER MET ASN GLU PHE ILE GLN SEQRES 18 A 1269 ASP PRO ALA LEU THR LEU MET HIS GLN LEU ILE TYR SER SEQRES 19 A 1269 LEU HIS GLY LEU TYR GLY ALA LYS GLY ILE THR THR LYS SEQRES 20 A 1269 TYR THR ILE THR GLN LYS GLN ASN PRO LEU ILE THR ASN SEQRES 21 A 1269 ILE ARG GLY THR ASN ILE GLU GLU PHE LEU THR PHE GLY SEQRES 22 A 1269 GLY THR ASP LEU ASN ILE ILE THR SER ALA GLN SER ASN SEQRES 23 A 1269 ASP ILE TYR THR ASN LEU LEU ALA ASP TYR LYS LYS ILE SEQRES 24 A 1269 ALA SER LYS LEU SER LYS VAL GLN VAL SER ASN PRO LEU SEQRES 25 A 1269 LEU ASN PRO TYR LYS ASP VAL PHE GLU ALA LYS TYR GLY SEQRES 26 A 1269 LEU ASP LYS ASP ALA SER GLY ILE TYR SER VAL ASN ILE SEQRES 27 A 1269 ASN LYS PHE ASN ASP ILE PHE LYS LYS LEU TYR SER PHE SEQRES 28 A 1269 THR GLU PHE ASP LEU ALA THR LYS PHE GLN VAL LYS CYS SEQRES 29 A 1269 ARG GLN THR TYR ILE GLY GLN TYR LYS TYR PHE LYS LEU SEQRES 30 A 1269 SER ASN LEU LEU ASN ASP SER ILE TYR ASN ILE SER GLU SEQRES 31 A 1269 GLY TYR ASN ILE ASN ASN LEU LYS VAL ASN PHE ARG GLY SEQRES 32 A 1269 GLN ASN ALA ASN LEU ASN PRO ARG ILE ILE THR PRO ILE SEQRES 33 A 1269 THR GLY ARG GLY LEU VAL LYS LYS ILE ILE ARG PHE CYS SEQRES 34 A 1269 LYS ASN ILE VAL SER VAL LYS GLY ILE ARG LYS SER ILE SEQRES 35 A 1269 CYS ILE GLU ILE ASN ASN GLY GLU LEU PHE PHE VAL ALA SEQRES 36 A 1269 SER GLU ASN SER TYR ASN ASP ASP ASN ILE ASN THR PRO SEQRES 37 A 1269 LYS GLU ILE ASP ASP THR VAL THR SER ASN ASN ASN TYR SEQRES 38 A 1269 GLU ASN ASP LEU ASP GLN VAL ILE LEU ASN PHE ASN SER SEQRES 39 A 1269 GLU SER ALA PRO GLY LEU SER ASP GLU LYS LEU ASN LEU SEQRES 40 A 1269 THR ILE GLN ASN ASP ALA TYR ILE PRO LYS TYR ASP SER SEQRES 41 A 1269 ASN GLY THR SER ASP ILE GLU GLN HIS ASP VAL ASN GLU SEQRES 42 A 1269 LEU ASN VAL PHE PHE TYR LEU ASP ALA GLN LYS VAL PRO SEQRES 43 A 1269 GLU GLY GLU ASN ASN VAL ASN LEU THR SER SER ILE ASP SEQRES 44 A 1269 THR ALA LEU LEU GLU GLN PRO LYS ILE TYR THR PHE PHE SEQRES 45 A 1269 SER SER GLU PHE ILE ASN ASN VAL ASN LYS PRO VAL GLN SEQRES 46 A 1269 ALA ALA LEU PHE VAL SER TRP ILE GLN GLN VAL LEU VAL SEQRES 47 A 1269 ASP PHE THR THR GLU ALA ASN GLN LYS SER THR VAL ASP SEQRES 48 A 1269 LYS ILE ALA ASP ILE SER ILE VAL VAL PRO TYR ILE GLY SEQRES 49 A 1269 LEU ALA LEU ASN ILE GLY ASN GLU ALA GLN LYS GLY ASN SEQRES 50 A 1269 PHE LYS ASP ALA LEU GLU LEU LEU GLY ALA GLY ILE LEU SEQRES 51 A 1269 LEU GLU PHE GLU PRO GLU LEU LEU ILE PRO THR ILE LEU SEQRES 52 A 1269 VAL PHE THR ILE LYS SER PHE LEU GLY SER SER ASP ASN SEQRES 53 A 1269 LYS ASN LYS VAL ILE LYS ALA ILE ASN ASN ALA LEU LYS SEQRES 54 A 1269 GLU ARG ASP GLU LYS TRP LYS GLU VAL TYR SER PHE ILE SEQRES 55 A 1269 VAL SER ASN TRP MET THR LYS ILE ASN THR GLN PHE ASN SEQRES 56 A 1269 LYS ARG LYS GLU GLN MET TYR GLN ALA LEU GLN ASN GLN SEQRES 57 A 1269 VAL ASN ALA ILE LYS THR ILE ILE GLU SER LYS TYR ASN SEQRES 58 A 1269 SER TYR THR LEU GLU GLU LYS ASN GLU LEU THR ASN LYS SEQRES 59 A 1269 TYR ASP ILE LYS GLN ILE GLU ASN GLU LEU ASN GLN LYS SEQRES 60 A 1269 VAL SER ILE ALA MET ASN ASN ILE ASP ARG PHE LEU THR SEQRES 61 A 1269 GLU SER SER ILE SER TYR LEU MET LYS LEU ILE ASN GLU SEQRES 62 A 1269 VAL LYS ILE ASN LYS LEU ARG GLU TYR ASP GLU ASN VAL SEQRES 63 A 1269 LYS THR TYR LEU LEU ASN TYR ILE ILE GLN HIS GLY SER SEQRES 64 A 1269 ILE LEU GLY GLU SER GLN GLN GLU LEU ASN SER MET VAL SEQRES 65 A 1269 THR ASP THR LEU ASN ASN SER ILE PRO PHE LYS LEU SER SEQRES 66 A 1269 SER TYR THR ASP ASP LYS ILE LEU ILE SER TYR PHE ASN SEQRES 67 A 1269 LYS PHE PHE LYS ARG ILE LYS SER SER SER VAL LEU ASN SEQRES 68 A 1269 MET ARG TYR LYS ASN ASP LYS TYR VAL ASP THR SER GLY SEQRES 69 A 1269 TYR ASP SER ASN ILE ASN ILE ASN GLY ASP VAL TYR LYS SEQRES 70 A 1269 TYR PRO THR ASN LYS ASN GLN PHE GLY ILE TYR ASN ASP SEQRES 71 A 1269 LYS LEU SER GLU VAL ASN ILE SER GLN ASN ASP TYR ILE SEQRES 72 A 1269 ILE TYR ASP ASN LYS TYR LYS ASN PHE SER ILE SER PHE SEQRES 73 A 1269 TRP VAL ARG ILE PRO ASN TYR ASP ASN LYS ILE VAL ASN SEQRES 74 A 1269 VAL ASN ASN GLU TYR THR ILE ILE ASN CYS MET ARG ASP SEQRES 75 A 1269 ASN ASN SER GLY TRP LYS VAL SER LEU ASN HIS ASN GLU SEQRES 76 A 1269 ILE ILE TRP THR LEU GLN ASP ASN ALA GLY ILE ASN GLN SEQRES 77 A 1269 LYS LEU ALA PHE ASN TYR GLY ASN ALA ASN GLY ILE SER SEQRES 78 A 1269 ASP TYR ILE ASN LYS TRP ILE PHE VAL THR ILE THR ASN SEQRES 79 A 1269 ASP ARG LEU GLY ASP SER LYS LEU TYR ILE ASN GLY ASN SEQRES 80 A 1269 LEU ILE ASP GLN LYS SER ILE LEU ASN LEU GLY ASN ILE SEQRES 81 A 1269 HIS VAL SER ASP ASN ILE LEU PHE LYS ILE VAL ASN CYS SEQRES 82 A 1269 SER TYR THR ARG TYR ILE GLY ILE ARG TYR PHE ASN ILE SEQRES 83 A 1269 PHE ASP LYS GLU LEU ASP GLU THR GLU ILE GLN THR LEU SEQRES 84 A 1269 TYR SER ASN GLU PRO ASN THR ASN ILE LEU LYS ASP PHE SEQRES 85 A 1269 TRP GLY ASN TYR LEU LEU TYR ASP LYS GLU TYR TYR LEU SEQRES 86 A 1269 LEU ASN VAL LEU LYS PRO ASN ASN PHE ILE ASP ARG ARG SEQRES 87 A 1269 LYS ASP SER THR LEU SER ILE ASN ASN ILE ARG SER THR SEQRES 88 A 1269 ILE LEU LEU ALA ASN ARG LEU TYR SER GLY ILE LYS VAL SEQRES 89 A 1269 LYS ILE GLN ARG VAL ASN ASN SER SER THR ASN ASP ASN SEQRES 90 A 1269 LEU VAL ARG LYS ASN ASP GLN VAL TYR ILE ASN PHE VAL SEQRES 91 A 1269 ALA SER LYS THR HIS LEU PHE PRO LEU TYR ALA ASP THR SEQRES 92 A 1269 ALA THR THR ASN LYS GLU LYS THR ILE LYS ILE SER SER SEQRES 93 A 1269 SER GLY ASN ARG PHE ASN GLN VAL VAL VAL MET ASN SER SEQRES 94 A 1269 VAL GLY ASN ASN CYS THR MET ASN PHE LYS ASN ASN ASN SEQRES 95 A 1269 GLY ASN ASN ILE GLY LEU LEU GLY PHE LYS ALA ASP THR SEQRES 96 A 1269 VAL VAL ALA SER THR TRP TYR TYR THR HIS MET ARG ASP SEQRES 97 A 1269 HIS THR ASN SER ASN GLY CYS PHE TRP ASN PHE ILE SER SEQRES 98 A 1269 GLU GLU HIS GLY TRP GLN GLU LYS HELIX 1 AA1 GLU A 95 ILE A 111 1 17 HELIX 2 AA2 GLY A 118 LYS A 126 1 9 HELIX 3 AA3 LEU A 184 TYR A 188 5 5 HELIX 4 AA4 ASP A 222 LEU A 238 1 17 HELIX 5 AA5 ILE A 266 GLY A 273 1 8 HELIX 6 AA6 THR A 281 LYS A 305 1 25 HELIX 7 AA7 LEU A 313 LYS A 317 5 5 HELIX 8 AA8 ASP A 318 LYS A 323 1 6 HELIX 9 AA9 ASN A 337 TYR A 349 1 13 HELIX 10 AB1 THR A 352 PHE A 360 1 9 HELIX 11 AB2 ILE A 394 VAL A 399 1 6 HELIX 12 AB3 ASN A 535 LYS A 544 1 10 HELIX 13 AB4 SER A 573 ASN A 581 1 9 HELIX 14 AB5 GLN A 585 ALA A 587 5 3 HELIX 15 AB6 LEU A 588 ASN A 605 1 18 HELIX 16 AB7 ASN A 637 GLY A 646 1 10 HELIX 17 AB8 ASN A 676 ILE A 710 1 35 HELIX 18 AB9 ILE A 710 VAL A 729 1 20 HELIX 19 AC1 ASN A 730 SER A 742 1 13 HELIX 20 AC2 ILE A 760 HIS A 817 1 58 HELIX 21 AC3 SER A 830 LEU A 836 1 7 HELIX 22 AC4 ASN A 945 ASN A 949 5 5 HELIX 23 AC5 ASP A 1072 GLU A 1083 1 12 HELIX 24 AC6 SER A 1172 LEU A 1176 5 5 SHEET 1 AA1 6 LEU A 36 ILE A 38 0 SHEET 2 AA1 6 TYR A 47 ASN A 51 -1 O SER A 49 N LEU A 36 SHEET 3 AA1 6 TRP A 57 ILE A 58 -1 O ILE A 58 N PHE A 50 SHEET 4 AA1 6 VAL A 165 ILE A 167 1 O ILE A 167 N TRP A 57 SHEET 5 AA1 6 ALA A 199 VAL A 201 1 O ALA A 199 N ILE A 166 SHEET 6 AA1 6 SER A 180 ASN A 181 -1 N SER A 180 O ILE A 200 SHEET 1 AA2 2 SER A 83 TYR A 85 0 SHEET 2 AA2 2 LEU A 421 LYS A 423 -1 O VAL A 422 N SER A 84 SHEET 1 AA3 2 VAL A 149 GLU A 150 0 SHEET 2 AA3 2 ILE A 160 LEU A 161 -1 O LEU A 161 N VAL A 149 SHEET 1 AA4 2 ARG A 210 PHE A 211 0 SHEET 2 AA4 2 PHE A 219 ILE A 220 -1 O PHE A 219 N PHE A 211 SHEET 1 AA5 2 THR A 249 ILE A 250 0 SHEET 2 AA5 2 THR A 264 ASN A 265 -1 O THR A 264 N ILE A 250 SHEET 1 AA6 2 ASP A 327 LYS A 328 0 SHEET 2 AA6 2 TYR A 334 SER A 335 -1 O SER A 335 N ASP A 327 SHEET 1 AA7 2 LYS A 376 LEU A 377 0 SHEET 2 AA7 2 ILE A 413 THR A 414 -1 O THR A 414 N LYS A 376 SHEET 1 AA8 2 MET A 872 ARG A 873 0 SHEET 2 AA8 2 VAL A 880 ASP A 881 -1 O VAL A 880 N ARG A 873 SHEET 1 AA9 2 ILE A 889 ILE A 891 0 SHEET 2 AA9 2 VAL A 915 ILE A 917 -1 O ASN A 916 N ASN A 890 SHEET 1 AB1 2 PHE A 905 GLY A 906 0 SHEET 2 AB1 2 GLY A1060 ILE A1061 -1 O ILE A1061 N PHE A 905 SHEET 1 AB2 3 ILE A1008 ILE A1012 0 SHEET 2 AB2 3 ILE A 934 VAL A 938 -1 N PHE A 936 O VAL A1010 SHEET 3 AB2 3 ASN A1065 ILE A1066 -1 O ASN A1065 N SER A 935 SHEET 1 AB3 5 LEU A 990 ASN A 993 0 SHEET 2 AB3 5 GLU A 975 GLN A 981 -1 N TRP A 978 O LEU A 990 SHEET 3 AB3 5 GLY A 966 ASN A 972 -1 N SER A 970 O ILE A 977 SHEET 4 AB3 5 TYR A 954 ASN A 958 -1 N TYR A 954 O LEU A 971 SHEET 5 AB3 5 LEU A1047 VAL A1051 -1 O LYS A1049 N ILE A 956 SHEET 1 AB4 2 ASP A1019 ILE A1024 0 SHEET 2 AB4 2 ASN A1027 SER A1033 -1 O ASN A1027 N ILE A1024 SHEET 1 AB5 2 TYR A1104 ASN A1107 0 SHEET 2 AB5 2 TRP A1257 ILE A1260 -1 O ASN A1258 N LEU A1106 SHEET 1 AB6 2 ASN A1113 ARG A1117 0 SHEET 2 AB6 2 LEU A1123 ILE A1128 -1 O ASN A1127 N PHE A1114 SHEET 1 AB7 2 ASN A1168 PHE A1169 0 SHEET 2 AB7 2 PHE A1177 PRO A1178 -1 O PHE A1177 N PHE A1169 SHEET 1 AB8 3 VAL A1204 SER A1209 0 SHEET 2 AB8 3 CYS A1214 LYS A1219 -1 O THR A1215 N ASN A1208 SHEET 3 AB8 3 ASN A1225 ILE A1226 -1 O ILE A1226 N PHE A1218 SHEET 1 AB9 2 LEU A1228 LEU A1229 0 SHEET 2 AB9 2 ALA A1238 SER A1239 -1 O SER A1239 N LEU A1228 SSBOND 1 CYS A 429 CYS A 443 1555 1555 2.04 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000